COVID-19 and SARS-CoV-2 Detection in Saliva

Completed

Conditions studied: RNA Virus Infections

In brief

This study aims to validate the use of human saliva as a substrate for an assay to detect SARS-CoV-2 and define accuracy, analytical sensitivity and specificity of the TaqPath RT-PCR test.

Key facts

Study ID

NCT04517682

Run by

Ambry Genetics

People needed

67

Starts

2020-05-21

Expected to finish

2021-08-05

Last updated by the study team

2022-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Reads and understands English or Spanish
• Willing and able to provide consent
• Diagnosed with COVID-19 or at high risk of disease based on objective criteria

You may not qualify if…

• Unwilling or unable to provide consent.
• Pregnant female

Where it is running

• Ambry Genetics — Aliso Viejo, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.